INVO Fertility, Inc. (IVF) - Total Liabilities
Based on the latest financial reports, INVO Fertility, Inc. (IVF) has total liabilities worth $12.98 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore INVO Fertility, Inc. net asset momentum to track the company's year-over-year net asset growth rate.
INVO Fertility, Inc. - Total Liabilities Trend (2006–2024)
This chart illustrates how INVO Fertility, Inc.'s total liabilities have evolved over time, based on quarterly financial data. See IVF free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
INVO Fertility, Inc. Competitors by Total Liabilities
The table below lists competitors of INVO Fertility, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Biosergen AS
ST:BIOSGN
|
Sweden | Skr13.04 Million |
|
Avinger Inc
NASDAQ:AVGR
|
USA | $9.73 Million |
|
Australian Bond Exchange Holdings Ltd
AU:ABE
|
Australia | AU$6.83 Million |
|
GeoVax Labs Inc
NASDAQ:GOVX
|
USA | $1.82 Million |
|
INCUVO S.A. ZY -50
F:68X
|
Germany | €2.42 Million |
|
Engineer Gold Mines Ltd
V:EAU
|
Canada | CA$708.84K |
|
Yida China Holdings Ltd
STU:YC2
|
Germany | €27.26 Billion |
|
Strategic Equity Capital Closed Fund
LSE:SEC
|
UK | GBX329.00K |
Liability Composition Analysis (2006–2024)
This chart breaks down INVO Fertility, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INVO Fertility, Inc. market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how INVO Fertility, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for INVO Fertility, Inc. (2006–2024)
The table below shows the annual total liabilities of INVO Fertility, Inc. from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $33.70 Million | +91.34% |
| 2023-12-31 | $17.61 Million | +275.76% |
| 2022-12-31 | $4.69 Million | +48.54% |
| 2021-12-31 | $3.16 Million | -39.36% |
| 2020-12-31 | $5.20 Million | -5.53% |
| 2019-12-31 | $5.51 Million | +57.33% |
| 2018-12-31 | $3.50 Million | -33.41% |
| 2017-12-31 | $5.26 Million | +7.23% |
| 2016-12-31 | $4.90 Million | +13.08% |
| 2015-12-31 | $4.34 Million | -2.92% |
| 2014-12-31 | $4.47 Million | +13.45% |
| 2013-12-31 | $3.94 Million | +12.56% |
| 2012-12-31 | $3.50 Million | +14.57% |
| 2011-12-31 | $3.05 Million | +14.65% |
| 2010-12-31 | $2.66 Million | -24.46% |
| 2009-12-31 | $3.52 Million | +256.73% |
| 2008-12-31 | $988.12K | +530.59% |
| 2007-12-31 | $156.70K | +62579.20% |
| 2006-12-31 | $250.00 | -- |
About INVO Fertility, Inc.
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body… Read more